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A B S T R A C T
Interest in the risks posed by trace concentrations of pharmaceuticals and personal care products (PPCPs) in
surface waters is increasing, particularly with regard to potential eﬀects of long-term, low-dose exposures of
aquatic organisms. In most cases, the actual studies on PPCPs were risk assessments at screening-level, and
accurate estimates were scarce. In this study, exposure and ecotoxicity data of 50 PPCPs were collected based on
our previous studies, and a multiple-level environmental risk assessment was performed. The 50 selected PPCPs
are likely to be frequently detected in surface waters of China, with concentrations ranging from the ng L−1 to
the low-g L−1, and the risk quotients based on median concentrations ranged from 2046 for nonylphenol to 0 for
phantolide. A semi-probabilistic approach screened 33 PPCPs that posed potential risks to aquatic organisms,
among which 15 chemicals (nonylphenol, sulfamethoxazole, di (2-ethylhexyl) phthalate, 17β-ethynyl estradiol,
caﬀeine, tetracycline, 17β-estradiol, estrone, dibutyl phthalate, ibuprofen, carbamazepine, tonalide, galaxolide,
triclosan, and bisphenol A) were categorized as priority compounds according to an optimized risk assessment,
and then the reﬁned probabilistic risk assessment indicated 12 of them posed low to high risk to aquatic eco-
system, with the maximum risk products ranged from 1.54% to 17.38%. Based on these results, we propose that
the optimized risk assessment was appropriate for screening priority contaminants at national scale, and when a
more accurate estimation is required, the reﬁned probability risk assessment is useful. The methodology and
process might provide reference for other research of chemical evaluation and management for rivers, lakes, and
sea waters.
1. Introduction
As one of the most important groups of contaminants of emerging
concern, the occurrence of pharmaceuticals and personal care products
(PPCPs) in the aquatic environments and their potential detrimental
eﬀects on aquatic organisms have given rise to major global concern in
recent years. Pharmaceuticals are human and veterinary medicines,
including antibiotics, β-blocking drugs, blood lipid regulators, antic-
onvulsant drugs, X-ray contrast media, and others. Personal care pro-
ducts (PCPs) are chemicals used in soaps, shampoos, conditioners,
toothpastes, skin care products, sunscreens, insect repellents, lotions,
and fragrances (Yu, 2011). It has been reported that more than 50,000
PPCPs are produced and around thirty million tons are consumed
worldwide (Yu, 2011). China exports more than 60% of the total active
pharmaceutical ingredients to the global pharmaceutical industry
(Rehman et al., 2015) and consumed more than 162,000 tons of anti-
biotics in 2013 (Zhang et al., 2015). Proportions of the global total of
PCPs consumed in China is approximately 6.5%, which is only exceeded
by the United States of America (19.1%) and Japan (9.4%) (CIRN,
2012).
While most PPCPs are not persistent, due to their mass production
and are used daily for various purposes, they are continually released
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into the aquatic environments via wastewater treatment plants
(WWTPs), agricultural runoﬀ, aquaculture, and PPCP manufacturing
sites (Barbara et al., 2008; Larsson et al., 2007; Sim et al., 2011), and
are typically considered as “pseudo-persistent” (Santos et al., 2010).
The contamination of PPCPs in surface waters has been extensively
studied in China and worldwide, with concentration ranging from
ng L−1 to μg L−1 (Ebele et al., 2017; Sun et al., 2015; Bu et al., 2013;
Liu et al., 2013; Balakrishna et al., 2017; Kuzmanović et al., 2015;
Thomaidi et al., 2015; Carmona et al., 2014; Tewari et al., 2013;
Scheurer et al., 2009). Although PPCPs are detected in surface waters at
relatively low concentrations, many of them and their metabolites are
biologically active and may impact non-target aquatic organisms at a
long-term exposure, including endocrine disruption, genotoxicity, car-
cinogenicity, fetal development (Jin et al., 2014). A major concern
raised by the presence of PPCPs in the aquatic environment is their
ability to interfere with the endocrine system to produce undesired
eﬀects/ disruption of homeostasis (Ebele et al., 2017). It has been re-
ported that more than 20% of PPCPs detected in surface waters were
estrogenic chemicals (Kolpin et al., 2002).
Historically, studies on the aquatic risk of PPCPs were most fre-
quently conducted using the simple, deterministic quotient method,
which was expressed as the exposure concentration divided by the ef-
fect concentration (Donnachie et al., 2016; Wang et al., 2017; Zhang
et al., 2017a; Zhang et al., 2017b; Vazquez-Roig et al., 2012). It is in-
evitable that there may be outliers within both eﬀect and exposure
datasets that may lead to bias or misinterpretation of risks. These might
include unrepeatable ecotoxicity results, perhaps with ambiguous end-
points or high environmental concentrations reported from one-oﬀ
measurements at localized, often more contaminated sites (Donnachie
et al., 2016). Moreover, these studies were mainly based on acute
toxicity data, and cannot adequately reﬂect the potential for chronic
eﬀects of long-term exposure to sub-acute levels (Godoy et al., 2015;
Carlsson et al., 2006), particularly with regard to reproductive ﬁtness,
which most accurately represents variations between populations and
species diversity for modulation of endocrine function in aquatic or-
ganisms (Jin et al., 2014; Liu et al., 2016a). Thus, a more accurate
evaluation of PPCPs based on chronic eﬀects is urgently needed.
According to the guidelines for ecological risk assessment developed
by the US EPA (1998), quantitative risk estimates can be developed on
the basis of measured data using one or more of the following techni-
ques: (1) single-point exposure and eﬀects comparisons, (2) comparing
an exposure distribution with a point estimate of eﬀects, and (3)
comparisons incorporating variability of exposure and eﬀects. Con-
sidering the complex eﬀects and the low frequency of detection, risk
characterization for PPCPs carried out by one method may be in-
suﬃcient for the protection of the aquatic environment in China. The
objectives of this study were to conduct a comprehensive evaluation of
PPCPs in Chinese surface waters using all the three techniques based on
chronic eﬀects and concentrations reported during the 12-year period
from 2006 to 2017, and to evaluate the protective capacity of this tiered
approach, which could provide a more rigorous scientiﬁc basis and
technical support for risk management options for PPCPs.
2. Materials and methods
2.1. PPCPs selected for this study
The 50 PPCPs (Table 1), on which this China-wide investigation
focused, were selected for study based on the results of previous pilot
studies (Liu, 2016), in which the risks of 144 PPCPs were assessed based
on maximum concentrations in waters and thresholds for the most
sensitive endpoints. If based on focused, regional studies, particular
PPCPs were deemed to be more likely to cause adverse eﬀects on
aquatic environments of China, and most likely to cause more wide-
spread issues. Among the 50 PPCPs, 44 were the prioritization of
compounds on the ﬁrst European Watch List (European Commission,
2015).
2.2. Evaluation and selection of data
2.2.1. Measured environment concentrations
The concentration data of 50 PPCPs in surface waters were obtained
from peer-reviewed publications and government reports published
between 2006 and 2017 by performing searches in National Knowledge
Infrastructure, Web of Sciences, Scopus and Google Scholar using the
keywords “pharmaceutical”, “drug”, “PCP”, “occurrence”, “pollutant”
or “concentration”. The data mainly came from chemical analysis of
samples collected in rivers and streams, followed by lakes, reservoirs,
and estuaries. In order to reﬂect the worst and the best case scenario in
Table 1
Relevant information and properties of the selected PPCPs.
Category Chemical CAS NO. Water
Solubility at
25
℃(mg L−1) a
log Kow a
antibiotic clarithromycin 81103–11-9 0.342 3.16
antibiotic erythromycin 114–07-8 1.44 3.06
antibiotic roxithromycin 80214–83-1 0.0189 2.75
antibiotic tylosin 1401–69-0 5 1.63
antibiotic trimethoprim 738–70-5 400 0.91
antibiotic sulfamethazine 57–68-1 1500 0.89
antibiotic sulfamethoxazole 723–46-6 6.1 0.89
antibiotic enroﬂoxacin 93106–60-6 3400 0.7
antibiotic cephalexin 15686–71-2 1790 0.65
antibiotic sulfapyridine 144–83-2 268 0.35
antibiotic sulfamethoxypyridazine 80–32-0 7000 0.31
antibiotic ciproﬂoxacin 85721–33-1 30,000 0.28
antibiotic sulfadiazine 68–35-9 77 −0.09
antibiotic oﬂoxacin 82419–36-1 28,300 −0.39
antibiotic chlorotetracycline 57–62-5 630 −0.62
antibiotic oxytetracycline 79–57-2 313 −0.9
antibiotic norﬂoxacin 70458–96-7 178,000 −1.03
antibiotic tetracycline 60–54-8 231 −1.3
hormone diethylstilbestrol 56–53-1 12 5.07
hormone 17β-estradiol 50–28-2 3.6 4.01
hormone 17β-ethynyl estradiol 57–63-6 11.3 3.67
hormone testosterone 58–22-0 23.4 3.32
hormone bisphenol A 80–05-7 120 3.32
hormone estrone 53–16-7 30 3.13
hormone androstenedione 63–05-8 57.8 2.75
hormone estriol 50–27-1 441 2.45
others gemﬁbrozil 25812–30-0 11 4.77
others indomethacin 53–86-1 0.937 4.23
others diclofenac 19367–86-5 2.37 4.02
others ibuprofen 15687–27-1 21 3.97
others propranolol 525–66-6 61.7 3.48
others naproxen 22204–53-1 15.9 3.18
others cloﬁbric acid 882–09-7 583 2.84
others salicylic acid 69–72-7 2240 2.26
others carbamazepine 298–46-4 17.7 2.25
others caﬀeine 58–08-2 21,600 −0.07
others iopromide 73334–07-3 23.8 −2.05
PCP di-n-octyl phthalate 117–84-0 0.02 8.1
PCP di(2-ethylhexyl) phthalate 117–81-7 0.27 7.6
PCP nonylphenol 25154–52-3 6.35 5.99
PCP galaxolide 1222–05-5 1.75 5.9
PCP tonalide 1506–02-1 1.25 5.7
PCP triclocarban 101–20-2 0.00237 4.9
PCP triclosan 3380–34-5 10 4.76
PCP dibutyl phthalate 84–74-2 11.2 4.5
PCP musk ketone 81–14-1 0.387 4.3
PCP diethyl phthalate 84–66-2 1080 2.42
PCP dimethyl phthalate 131–11-3 4000 1.6
PCP traseolide 68140–48-7 NRb NRb
PCP phantolide 15323–35-0 NRb NRb
Note: a. Water Solubility and log Kow (octanol–water coeﬃcient) from
ChemIDPlus Advanced (http://chem.sis.nlm.nih.gov/chemidplus/) and
PubChem (https://pubchem.ncbi.nlm.nih. gov/), U.S. National Library of
Medicine. b. NR refers to not reported.
N. Liu, et al. Environment International 136 (2020) 105454
2
freshwater ecosystems, concentrations in receiving waters and drinking
water sources were included. Given the number of studies in the lit-
erature, the mean concentration for a location was calculated using
measured values if greater than the method detection limits (MDL), the
1/2 MDL if < MDL or 0 if not detected. Once the datasets for en-
vironmental concentrations at the national scale were considered suf-
ﬁcient, the information was plotted to be evaluated and the 95th, 75th,
50th and 25th centile concentrations were calculated. The purpose of
these measures is to describe the upper end of the exposure distribution,
allowing researchers to evaluate whether certain locations indicate
disproportionate large risks (US EPA, 1996).
2.2.2. Environmental toxicity information
Toxic potencies for the eﬀects of 50 PPCPs on non-target organisms
were retrieved from the ECOTOX Knowledgebase (https://cfpub.epa.
gov/ecotox/search. cfm) developed by the US EPA, following the
principles of accuracy, relevance and reliability according to Klimisch
et al. (1997), Durda et al. (2000), Hobbs et al. (2005), US EPA (2011),
Moermond et al. (2016). In these ﬁve methods or guidelines, there are
ﬁve evaluate criteria for the quality of ecotoxicity data as follow: (1)
test design, including guideline method, experimental process, the va-
lidity of the test results and quality controls; (2) the purity of the test
substances and other ingredients in formulation; (3) general informa-
tion and source of test organisms; (4) exposure conditions, including the
experimental system appropriate for the test substance, the experi-
mental system appropriate for the test organisms, the reliability of
nominal concentration, the spacing between test concentrations, ex-
posure duration, verify concentration and biomass loading; (5) data
analysis, including replicate, statistical method, concentration-response
curve and raw data (Liu et al., 2016b). Toxicity data were selected using
a hierarchical method and chronic toxicity data of no observed eﬀect
concentrations (NOECs) or EC10 for the most sensitive eﬀect measure-
ments were preferred (EC, 2003). In the absence of NOEC or EC10, the
lowest observed eﬀect concentration (LOEC) or the median eﬀect
concentration (EC50) was used with assessment factor (AF) of 2 or 10
(EC, 2003; Bu et al., 2013).
2.3. Assessment of risks
The multiple-level ecological risk assessment (MLERA) of PPCPs
was conducted according to the Framework for ecotoxicological risk
assessment (US EPA, 1998, US EPA, 1992), the Technical Guidance
Document on risk assessment (EC, 2003), NORMAN prioritisation fra-
mework for emerging substances (NORMAN Association, 2013), and
previous studies (Zhou et al., 2019; Desbiolles et al., 2018; Ohe et al.,
2011). A brief summary of the method is described in the following
sections.
2.3.1. Tier-1 risk quotient (RQ): A screening-level risk assessment.
The ecological risks caused by 50 PPCPs in surface waters of China
were assessed by use of deterministic quotient approach. Chronic and
sublethal deterministic risk quotients (RQs) were calculated as quo-
tients of the median concentration of individual chemicals in waters
divided by the predicted no eﬀect concentration (PNEC) (Eq. (1)). The
preliminary risk assessment ranks of PPCPs were classiﬁed as insignif-
icant if RQ < 0.1; low risk if 0.1 ≤ RQ < 1; moderate risk if
1 ≤ RQ < 10, and high risk if RQ ≥ 10 (Bu et al., 2013; Ågerstrand,
2010).
=RQ C
PNEC
m
(1)
Where Cm is the median concentration calculated from the collec-
tion of values for a single chemical measured at an individual location;
PNEC is the predicted no eﬀect concentration derived by the most
sensitive toxicity data with AFs of 10, 20, or 100 depending on test
endpoints of NOEC or EC10, LOEC, EC50 (Bu et al., 2013; Tarazona
et al., 2010).
2.3.2. Tier-2 frequency of PNEC exceedance: A semi-probabilistic
approach.
Using median concentrations as a comparator provides a robust
method to compare relative risks from chemicals. However, this relative
risk index does not reveal to what degree any of the chemicals might
actually be harming aquatic organisms at a national scale. So, a semi-
probabilistic risk assessment approach was conducted according to the
Framework for ecotoxicological risk assessment (US EPA, 1998, US
EPA, 1992). In brief, concentrations of a chemical lower than PNEC are
considered as safe, while concentrations exceeding PNEC might pose a
risk to aquatic organisms. Measured concentrations of target chemicals
at individual sampling sites were compared to PNEC values to de-
termine the frequency of PNEC exceedance. PPCPs were then prior-
itized by the proportion of concentrations that exceeded the PNEC
(Johnson et al., 2018).
= ×F n
N
100% (2)
where F is the frequency of PNEC exceedance, n is the number of sites
with concentrations above PNEC and, N is the total number of sampling
sites for a chemical. The resulting value indicates the share of sites
where potential eﬀects are expected (Ohe et al., 2011).
2.3.3. Tier-3 prioritization indexes: An optimized risk assessment.
Since the current RQ approach based on median concentrations in
water could be skewed by the frequency of detection. It is a tendency to
consider both concentration and frequency during the high-risk com-
pound screening. Thus, an optimized risk assessment was carried out
according to a methodology developed within the NORMAN Network
(NORMAN Association, 2013; Zhou et al., 2019; Desbiolles et al., 2018;
Tousova et al., 2017). Prioritization index (PI) was calculated, as the
result of the RQ value multiplied by the frequency of PNEC exceedance,
to highlight the PPCPs of greatest concern in surface waters of China,
which are close to the natural scenario and favors the selection of
priority pollutants.
= ×PI RQ F (3)
where PI is prioritization index, RQ is risk quotient calculated based on
median concentration and PNEC, F is the frequency of concentrations
exceeding PNEC.
2.3.4. Tier-4 Joint probability curves (JPCs): A reﬁned probability risk
assessment.
The approaches used in the previous assessments of risk are de-
pendent on the selection of PNECs, which are derived from single-
species toxicity tests, and failure to protect diverse ecosystems (Mebane
et al., 2010). For chemicals that posed high risk, it would be valuable to
characterize their risk for various species at national scale. Thus, JPCs
were adopted to identify chemicals that are most likely to have adverse
eﬀects on the widest range of species in the widest range of locations/
times. In this method, positively detected concentrations in surface
waters of China and chronic toxicity data for responses of various
species were compiled and transformed to probits by ﬁtting appropriate
distributions. Linear regressions of the two data sets can then be used to
calculate probabilities of concentrations causing adverse eﬀects to a
speciﬁed proportion (%) of species. Each point on the curve represents
both the probability that the chosen proportion of species will be af-
fected (magnitude of eﬀect) and the frequency with which that mag-
nitude of eﬀect would be exceeded in surface waters (exceedance
probability). The closer the JPC is to the axes, the less the probability of
adverse eﬀects (Solomon et al., 2000). To facilitate communication of
the risk outputs, the risk products (risk product = exceedance prob-
ability × magnitude of eﬀect) were then used to categorize risk as de
minimis, low, intermediate, or high based on the criteria described in
N. Liu, et al. Environment International 136 (2020) 105454
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Moore et al. (2010), Moore et al. (2014), Aslund et al. (2016), and
Clemow et al. (2018), in which the risk categories are deﬁned as fol-
lows:
If the maximum risk product was< 0.25%, then the risk was cate-
gorized as de minimis.
If the maximum risk product was ≥0.25% but< 2%, then the risk
was categorized as low.
If the maximum risk product was ≥2% but< 10%, then the risk
was categorized as intermediate.
If the maximum risk product was ≥10%, then the risk was cate-
gorized as high.
3. Results and discussion
3.1. PPCPs occurrence in Chinese surface waters
In total, 1934 exposure data of 50 target chemicals (Table S1) were
collected from 26 secondary river system regions, spread over the sever
river watersheds of China (Songliao River, Hai River, Yellow River,
Huai River, Yangtze River, Southeast coast, Pearl River) (Fig. 1). The 26
secondary river system regions recovering most of the high population
density area that reﬂected by the famous geographic “Hu Huanyong
line” (Zhang et al., 2015), and 20 regions located in eastern coastal
China. Pearl River Delta analyzed the most PPCPs (42), followed by
Yangtze River downstream (38), Taihu Lake (38), Daqing River (36),
Chaobai-Beiyun-Jiyun River (34), and Liao River (33). Liaodong Pe-
ninsula (14,718,411 ng L−1) and Yangtze River downstream
(731,100 ng L−1) showed the highest concentration, followed by Ziya
River (97,434 ng L−1), and Huai River (81,250 ng L−1). The most
frequently reported watershed was Yangtze River (ID: 14–18), where
643 samples were reported and approximately 96% (43 out of 45) of
the analyzed PPCPs were detected at concentrations above the limit of
detection levels. PPCPs were most commonly found in Hai River (ID:
5–9), where 45 chemicals were analyzed and positively detected in 489
samples. Followed by Pearl River (ID: 21–26), where 46 PPCPs was
analyzed and 44 of them were positively detected in 352 samples. It
should be noted that studies in some watersheds were quite limited, for
example, only 52 and 41 samples were reported in Yellow River (ID: 10)
and Huai River (ID: 21, 22) respectively, and further studies should be
done considering their 100% detection frequency.
Fig. 2 shows measured environmental concentrations of each com-
pound and the frequencies of detection shown as the number of posi-
tively detected/all data points. Nationally, except for phantolide, PPCPs
were frequently detected in Chinese surface waters (50% to 100%).
Among the 50 targeted PPCPs, 23 were found in over 90% of samples.
Predominant PCPs groups, such as phthalic acid esters (di-n-octyl
phthalate, di (2-ethylhexyl) phthalate, and dibutyl phthalate), were
detected frequently (67% to 100%) and at highest concentration levels
(up to 14,718,411 ng L−1) (Yao et al., 2011). The antibiotic sulfa-
methoxazole was the most concerned and investigated chemical, which
was positively detected at over 95% of 120 sites collected in 7 water-
sheds. The highest concentration of sulfamethoxazole (984 ng L−1) was
similar to that in India (900 ng L−1) (Balakrishna et al., 2017), but
lower than those in Europe (11,920 ng L−1) (Zhou et al., 2019),
America (1,500 ng L−1) (Fang et al., 2019) and Australia
(2,000 ng L−1) (Watkinson et al., 2009). The most ubiquitous anti-
biotics were erythromycin and sulfadiazine. Erythromycin was detected
in 97% of 65 samples with the highest concentration of 1,418 ng L−1
detected in Yangtze River (Yao et al., 2017), similar to those in Europe
(1,700 ng L−1) (Zhou et al., 2019). Compared to Europe, sulfadiazine
was more frequently detected (97%) in China but with lower exposure
concentrations.
Among the seven hormones, the highest concentration was found
for estriol in Yangtze River (67 ng L−1) (Zhang et al., 2014), lower than
in European surface waters (up to 480 ng L−1), while the frequency of
detection (61%) in all the 36 samples was higher than that found in
Europe (20%) (Zhou et al., 2019). The most frequently studied hormone
was estrone, occurring in 96% of 53 samples in seven watersheds. The
concentrations of estrone in China (0.12–57 ng L−1) were comparable
to those in European countries (up to 89 ng L−1) (Zhou et al., 2019).
Especially, androgens androstenedione and testosterone were less re-
ported globally, but were detected with 100% frequency in three Chi-
nese watersheds with concentrations between 2 and 28 and
0.2–2.5 ng L−1.
For other pharmaceutical groups, the highest concentration was
found for iopromide in Yangtze River (26,000 ng L−1) (Zhao et al.,
2012). The psychoactive stimulant caﬀeine was positively detected in
all 23 analyzed samples up to a concentration level of 3,712 ng L−1 in a
river receiving treated wastewater in Beijing (Zhou et al., 2010), ﬁve
times higher than the reported maximum concentration in Ganges River
(743 ng L−1) in India (Sharma et al., 2019), and one order of magnitude
lower than those detected in Europe waters (up to 39,813 ng L−1) (Loos
et al., 2009), what may be caused by diﬀerences in use and release. The
most popularity studies were carbamazepine and ibuprofen.
Fig. 1. Total number of PPCPs analyzed (a) and the highest concentration (b) in
Chinese surface waters by river system region. The secondary river system re-
gions IDs: 1. Songhua River; 2. Liao River; 3. Daling River; 4. Liaodong
Peninsula; 5. Zhangweinan Canal; 6. Yongding River; 7. Daqing River; 8. Ziya
River; 9. Chaobai-Beiyun-Jiyun River; 10. Yellow River; 11. Shandong
Peninsula; 12. Huai River; 13. Yangtze River Upstream; 14. Yangtze River
Downstream; 15. Jialing River; 16. Dongting Lake; 17. Poyang Lake; 18. Taihu
Lake; 19. Qiantang River; 20. Mindong-Yuedong; 21. Xijiang River; 22. Beijiang
River; 23. Dongjiang River; 24. Pearl River Delta; 25. Hainan; 26. Yueguiqiong.
Watersheds IDs: 1–4. Songliao River; 5–9. Hai River; 10. Yellow River; 11–12.
Huai River; 13–18. Yangtze River; 19–20. Southeast coast; 21–26. Pearl River.
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Carbamazepine was found in 93% of 42 samples collected in seven
watersheds, with the highest concentration of up to 1,090 ng L−1 (Zhou
et al., 2011), slightly lower than that reported from Europe (up to
1700 ng L−1) (Fang et al. 2019), and much higher than the con-
centration range commonly reported in other regions of the world
(Vieno et al., 2007; Nakada et al., 2007; Kumar et al., 2010; Sharma
et al., 2019). Ibuprofen was detected in 32 out of 36 sites, with the
highest concentration of 360 ng L−1, two orders of magnitude lower
than that reported in Europe (up to 31,323 ng L−1) (Zhou et al., 2019).
In most cases, the mean concentrations were approximately equal to
75th centiles. While, due to a wide range of concentration in various
samples, the distribution of concentrations of residues were skewed to
the right (positive skewness). In the present study, 17 mean con-
centrations were higher than the 75th centile by 2-fold. For example,
the mean concentrations of dimethyl phthalate and carbamazepine
were higher than the 75th centile values by 9 and 5 times, respectively,
with detection frequencies of 81% and 93%. Furthermore, in these 17
compounds, the mean concentrations for six PPCPs, di-n-octyl phtha-
late, oxytetracycline, chlorotetracycline, diethyl phthalate, dibutyl
phthalate, and di (2-ethylhexyl) phthalate, were higher than the 95th
centile. This demonstrates how the mean can be skewed by a few higher
concentrations, and therefore the results of risk assessment based on
median concentrations would be less uncertainty.
3.2. Toxic potencies of PPCPs
For use in this study, available chronic data for aquatic organisms
were secured for 50 PPCPs tested (Table 2). The results displayed here
possibly represent the most sensitive endpoints yet collated for the 50
PPCPs. All the 50 PPCPs may cause eﬀects on growth, development, or
reproduction of aquatic organisms. The data set contained single-spe-
cies toxicity data for 29 taxa, of which 9 were vertebrates, 11 were
invertebrates and 9 were primary producers. The thresholds for chronic
toxicity endpoints for vertebrates ranged from 0.03 to
1.2 × 104 ng L−1; for invertebrates, from 0.1 to 1 × 109 ng L−1; and
for primary producers, from 1.6 × 103 to 3.2 × 107 ng L−1.
From this collection of 18 antibiotics, 13 of them appear to be more
toxic to primary producers, and the other 5 antibiotics were more toxic
to aquatic animals. EC50 for most antibiotics in lower aquatic organisms
(alga and microorganism) were μg L−1-mg L−1, which were 100 to
1000 times more sensitive than higher organisms (Chen et al., 2012;
Meng et al., 2015). In comparison, aquatic vertebrates were more
sensitive to eﬀects of PCPs, and ﬁshes were more sensitive to hormones
and other pharmaceuticals.
3.3. Risk characterization
3.3.1. RQs of 50 PPCPs based on median concentrations
The 50 PPCPs were ranked by RQ values in descending order
(Fig. 3). For 9 compounds, the RQ values were higher than 10, meaning
high environmental risks in Chinese surface waters according to this
approach, among which sulfamethoxazole posed the second highest risk
to aquatic organisms, with a RQ of 1955, because of its toxic potency to
Caenorhabditis elegans (Yu et al., 2011). For 7 compounds the yielded
RQ values were between 1 and 10, which would mean that a moderate
environmental risk was probable. Among these 16 PPCPs that posted
certain risk to aquatic organisms (RQ ≥ 1), PCPs made the largest
contribution (8 out of 16), followed by hormones (3 out of 16) and
other pharmaceuticals group (3 out of 16). Antibiotics were the most
important group in this study, due to their large amount of consumption
and extensively reported, but only sulfamethoxazole and tetracycline
were identiﬁed as high risk in Chinese surface waters. This is expected
because the hydrophilicity of antibiotics led to the relatively less toxi-
city to aquatic organisms. A similar result was achieved by the pre-
dicted environmental concentration and ecological eﬀects conducted by
Sui et al. (2012), in their study, only 32% of the antibiotics were listed
as priority pharmaceuticals.
3.3.2. Characterization of semi-probabilistic risk
While using median concentrations can distort the analysis and
therefore be over- cautionary, an alternative is to quantify the prob-
ability of concentrations of PPCPs in surface waters exceeding the PNEC
Fig. 2. Box and whisker plots of measured concentrations of 50 target chemicals in 1934 water samples. Concentrations for each sample are shown as individual
points. The horizontal lines represent 95th centiles, and the boxes represent 25th and 75th centiles. The color indicates the categorization of compounds: orange:
personal care products, green: other pharmaceuticals, blue: antibiotics, red: hormone. Median and mean concentrations are shown as solid horizontal lines. The
numbers for each chemical indicate frequencies of detection, shown as the number of positively detected/all data points per data set, for example, di-n-octyl
phthalate, ranked 1st, with 26 positively detected samples from 39 samples.
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for aquatic organisms. The percentage of monitoring values which ex-
ceed PNEC values can be identiﬁed. In this case, 33 PPCPs (Fig. 4) in
surface waters of China were predicted with adverse eﬀects on some
sensitive species. In this group, the highest likelihood of exceeding
PNECs (100% of monitoring values) were nonylphenol, caﬀeine, tona-
lide, and galaxolide. Closely followed, with more than 90% of mon-
itoring values exceeding the PNEC were estrone, sulfamethoxazole,
bisphenol A, and di (2-ethylhexyl) phthalate. As expected, a possible
threat (1–10%) were observed for 6 chemicals (roxithromycin, di-n-
octyl phthalate, clarithromycin, trimethoprim, oxytetracycline, chlor-
otetracycline) that indicated as insigniﬁcant risks using the RQ method.
The frequencies of PNEC exceedance of the remaining 17 PPCPs were
zero, meaning that no ecotoxicological risk to aquatic organisms is to be
expected at current environmental concentrations. In a case study
performed in Greece by Thomaidi et al. (2015), for 25/25 rivers, 22/25
rivers, and 20/25 rivers, triclosan, caﬀeine and nonylphenol presented
RQ values higher than 1, respectively. Additionally, sulfamethoxazole,
bisphenol A, and oﬂoxacin presented RQ > 1 in two rivers. These
results indicated that the distribution of concentrations in surface wa-
ters is an important factor to consider when ranking the potential risks
of PPCPs.
In order to prioritize chemicals more reasonable, it was essential to
compare the results of the semi-probabilistic approach with the fre-
quency of detection. For example, the proportions of 17β-ethynyl es-
tradiol and 17β-estradiol that exceeded their respective PNECs were
68% and 69% respectively, approaching the frequency of detection
68% and 74%. Thus, aquatic organisms could be at risk once such
chemicals were detected in waters. According to Burns et al. (2018),
risk-based and hazard-based methods identiﬁed estrone, 17β-estradiol,
17β-ethynyl estradiol, and testosterone as the highest priority, despite
Table 2
Toxic potencies of four categories of PPCPs to aquatic organismsa.
Category Chemicals Species Class Eﬀect Duration
(days)
Endpoint Concentration
(ng L−1)
AF PNEC
(ng L−1)
antibiotic sulfamethoxazole Caenorhabditis elegans Worm Morphology 4 EC10 0.1 10 0.01
antibiotic tetracycline Gambusia holbrooki Fish Biochemical 4 LOEC 5 20 0.25
antibiotic norﬂoxacin Microcystis aeruginosa Alage Population 6 NOEC 1600 10 160
antibiotic clarithromycin Pseudokirchneriella subcapitata Alage Population 3 NOEC 2000 10 200
antibiotic erythromycin Synechococcus leopoliensis Alage Population 6 NOEC 2000 10 200
antibiotic oﬂoxacin Microcystis aeruginosa Alage Population 5 EC50 21,000 100 210
antibiotic sulfapyridine Lemna gibba Alage Population 4 NOEC 4600 10 460
antibiotic roxithromycin subcapitata Alage Population 3 LOEC 10,000 20 500
antibiotic sulfadiazine Phaeodactylum tricornutum Alage Population 4 NOEC 10,000 10 1000
antibiotic trimethoprim Brachionus koreanus Rotifer Genetic 1 NOEC 10,000 10 1000
antibiotic enroﬂoxacin Penaeus monodon Crustacean Growth 4 NRb 11,000 10 1100
antibiotic chlorotetracycline Oreochromis niloticus Fish Growth 48 NOEC 12,000 10 1200
antibiotic oxytetracycline Egeria densa -Population Plant Population 42 NOEC 20,000 10 2000
antibiotic ciproﬂoxacin Lemna gibba Plant Population 7 NOEC 100,000 10 10,000
antibiotic tylosin Lemna gibba Plant Population 7 NOEC 100,000 10 10,000
antibiotic sulfamethazine Lemna gibba Plant Population 7 NOEC 300,000 10 30,000
antibiotic cephalexin Lemna gibba Plant Population 7 NOEC 1,000,000 10 100,000
antibiotic sulfamethoxypyridazine Chlorella fusca var. vacuolata Alage Population 1 EC50 32,250,000 100 322,500
hormone 17β-ethynyl estradiol Oryzias latipes Fish Morphology 100 NOEC 0.03 10 0.003
hormone testosterone Oncorhynchus kisutch Fish Reproduction 21 LOEC 30 20 1.5
hormone 17β-estradiol Oncorhynchus mykiss Fish Reproduction 50 NOEC 0.42 10 0.042
hormone estrone Oncorhynchus mykiss Fish Vitellin 14 NOEC 0.74 10 0.074
hormone estriol Oryzias latipes Fish Hatch 15 NOEC 46.5 10 4.65
hormone androstenedione Poecilia reticulata Fish Morphology 12 ~ 14 NOEC 700 10 70
hormone diethylstilbestrol Nitocra Spinipes Copepod Reproduction 15–18 NOEC 3000 10 300
others caﬀeine Salmo salarc Fish Growth 5 NOEC 10 10 1
others ibuprofen Gammarus pulex Crustaceans Behavior 0.0833 LOEC 10 20 0.5
others gemﬁbrozil Danio rerioc Fish Genetic 7 LOEC 380 20 19
others diclofenac Oncorhynchus mykiss Fish Morphology 21 LOEC 460 20 23
others carbamazepine Gammarus pulex Crustaceans Behavior 0.0833 NOEC 10 10 1
others indomethacin Danio rerioc Fish Reproduction 16 NOEC 1000 10 100
others cloﬁbric acid Oncorhynchus mykiss Fish Morphology 28 NOEC 1000 10 100
others propranolol Oryzias latipes Fish Hormone 28 NOEC 1000 10 100
others naproxen Limnodynastes peroniid Amphibians Developmental 21 NOEC 10,000 10 1000
others salicylic acid Daphnia longispina Crustaceans Reproduction 21 NOEC 1,000,000 10 100,000
others iopromide Daphnia magna Crustaceans Reproduction 22 NOEC 1,000,000,000 10 100,000,000
PCP nonylphenol Danio rerioc Fish Genetic 3 LOEC 2.2 20 0.11
PCP tonalide Dreissena polymorphad Molluscs Physiological 7 NOEC 20.5 10 2.05
PCP triclocarban Americamysis bahiac Crustaceans Reproduction 28 NOEC 60 10 6
PCP galaxolide Dreissena polymorphad Molluscs Physiological 4 ~ 21 NOEC 97 10 9.7
PCP bisphenol A Oryzias latipes Fish Reproduction 4 NOEC 100 10 10
PCP triclosan Ruditapes philippinarum Molluscs Reproduction 7 NOEC 300 10 30
PCP di (2-ethylhexyl) phthalate Oryzias latipes Fish Developmental 90 NOEC 1000 10 100
PCP traseolide crucian Fish Physiological NR NOEC 1500 10 150
PCP phantolide crucian Fish Physiological NR NOEC 1500 10 150
PCP dibutyl phthalate Danio rerioc Fish Biochemical 4 LOEC 5000 20 250
PCP musk ketone Danio rerioc Fish Physiological 2 NOEC 3300 10 330
PCP diethyl phthalate Danio rerioc Fish Genetic 4 NOEC 5000 10 500
PCP di-n-octyl phthalate Haliotis diversicolor Molluscs Developmental 4 NOEC 20,000 10 2000
PCP dimethyl phthalate Haliotis diversicolor Molluscs Developmental 4 NOEC 20,000 10 2000
Note: a. Toxicology data of 50 PPCPs were retrieved from the ECOTOX Knowledgebase (https://cfpub.epa.gov/ecotox/search.cfm). b. NR refers to not reported. c.
Salmo sala, Danio rerio, and Americamysis bahia were nonnative species but standard test species. d. Limnodynastes peronii and Dreissena polymorpha were neither
nonnative species nor standard test species.
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they were not selected in any of the exposure-based exercises, in-
dicating that the perceived risks of these chemicals are more likely a
result of toxicity than high exposure. This is expected because they are
potent to some species.
3.3.3. Optimization of screening-level risk assessment for 33 PPCPs.
Fig. 5 shows 33 prioritized PPCPs according to prioritization in-
dexes in descending order. Prioritization indexes ranged from 2046 for
nonylphenol to 4.9 × 10−5 for chlorotetracycline. Compared to the RQ
value, prioritization indexes showed a greater diﬀerence in the poten-
tial environmental risks of the compounds that presented a lower fre-
quency of concentrations exceeding PNECs. For the 15 PPCPs those
posed high or moderate risk with the RQ method were still identiﬁed as
risk due to their great frequency of exceedance (≥59%). For the 3
PPCPs (estriol, testosterone, dimethyl phthalate), however, class of risk
were downgraded from a low risk with RQ method to an insigniﬁcant
risk with prioritization indexes, because they presented a lower
frequency of exceedance. Thus, by considering the variability of con-
centrations above PNECs, the optimized risk assessment method is more
convenient to select contaminants that should be prioritized in a large-
scale water resources management.
Among these 15 compounds with high or moderate environmental
risks, ﬁve of them (nonylphenol, caﬀeine, carbamazepine, ibuprofen,
and triclosan) were included in the priority list of the European
Demonstration Program (EDP) on the basis of their frequency and ex-
tent of exceedance of PNECs (Tousova et al., 2017). Similarly, six
compounds, i.e. 17β-ethynyl estradiol, ibuprofen, carbamazepine, caf-
feine, 17β-estradiol, and triclosan were identiﬁed as high or moderate
risk in the priority list of pharmaceuticals in European surface waters
(Zhou et al., 2019). Galaxolide and nonylphenol was identiﬁed as very
important and important contaminants in Sava River, Croatia (Smital
et al., 2013). Nonylphenol was also found among the ten most im-
portant contaminants within a prioritization exercise from Spain car-
ried out by Kuzmanović et al. (2015).
Fig. 3. Risk ranking of 18 antibiotics, 7 hormone, 11 other pharmaceuticals, and 14 PCPs, based on eﬀect concentration for the most sensitive species and the median
concentrations in surface waters. Colors refer to the chemical groups.
Fig. 4. Proportions (%) of concentrations of 33 PPCPs detected in surface wa-
ters of China that exceeded PNEC. Colors refer to the chemical groups.
Fig. 5. 33 Prioritized PPCPs according to prioritization indexes in descending
order. Colors refer to the chemical groups.
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3.3.4. Reﬁned risk assessment for twelve PPCPs.
For the 15 PPCPs that posed ecological risks identiﬁed by the
prioritization indexes, a reﬁned probability risk assessment based on
variability in exposure and ecotoxicity data was required. Joint prob-
ability curves for each compound, excluding tonalide, galaxolide and
triclosan for which less exposure data were available, were derived by
integrating the distribution for surface water concentrations with
chronic toxicity eﬀects on varies species to indicate the probability of
exceeding eﬀects of diﬀering magnitudes (Fig. 6). In the case of JPCs,
the measured environment concentrations and toxicity data used are
reported in the Supporting Information (Table S1 and S2). Data sets for
each chemical were tested for normality by use of the Shapiro-Wilk test
(p < 0.05) prior to application of parametric statistics (Table S3).
It is not surprising that JPCs of the three hormones were parallel due
to their similar modes of action on aquatic species, with a relative rank
of risks was as follows: 17β-ethynyl estradiol > estrone > 17β-es-
tradiol. For the same reason, the two antibiotics and the two phthalates
are also parallel to each other, with an order of risk at the national scale
of: sulfamethoxazole > tetracycline, di (2-ethylhexyl) phthalate >
dibutyl phthalate. Based on these results, the twelve PPCPs posed low
to high risks to aquatic organisms at the national scale. Chronic risk for
17β-ethynyl estradiol, caﬀeine, sulfamethoxazole and estrone were
categorized as high, with maximum risk product of 17.38%, 13.77%,
13.76%, and 12.39%, respectively. For carbamazepine, the results in-
dicate a low risk of chronic eﬀects in all surface waters of China
(maximum risk product of 1.54%). Intermediate risk of chronic eﬀects
on aquatic organisms was identiﬁed for the other seven PPCPs, with
maximum risk products ranged from 3% to 9.21%.
Results from the estimated risk curves can also be used to describe
the probability of exceeding percentages of taxa that would be aﬀected.
The probability of exceeding 5% adverse eﬀect depended on the most
sensitive species, while the shape of the risk curve was related to the
ranges and variability of datasets (Fig. 7) that could be described by
coeﬃcients of variation (CV). For example, JPCs for ibuprofen and bi-
sphenol A were classiﬁed as intermediate risk to 5–10% species, and a
low risk to 15–20% species. This is because both chemicals were pre-
dicted to exhibit toxicity to a small subgroup, with a large CV for eﬀect
data and a small value of exposures (Table S3). Alternatively, the JPCs
for di (2-ethylhexyl) phthalate and dibutyl phthalate decreased more
slowly, and represented an intermediate risk to a wider range of species
(from 5% to>70%). That was because the CVs for estimates of
exposure were much larger than those for relative potencies among
species and the maximum exposure data were larger than those for
toxic potencies. Because their exposure data were mainly distributed in
lower concentrations that were slightly higher than the most sensitive
species, with a low CV of exposure and a higher CV of eﬀect, 17β-
ethynyl estradiol, sulfamethoxazole, caﬀeine, and estrone presented
high risks to some species, but insigniﬁcant risks to 60% of species at
the national scale.
3.3.5. Comparing results of risk assessment produced by the four methods
Comparing the results of the risk assessment of the four methods
(Table 3), it appears that there is an advantage for the implementation
of the multiple-level system. The RQ can be useful in answering whe-
ther the relative risks are higher or lower, but a disadvantage of this
method is that outliers for estimates of exposure or relative potencies
occur. The semi-probabilistic approach provided the possibility of
chemicals that posed an ecological risk to aquatic organisms at the
national scale. And in the optimized risk assessment, both concentra-
tion and frequency were considered, what could make for the utility of
the results. For example, the RQ of di-n-octyl phthalate (1 9 0) was
similar to that of 17β-estradiol (1 6 3), while the frequency of PNEC
exceedance of di-n-octyl phthalate was much lower (10%) than that of
17β-estradiol (81%), so that the results obtained with the optimized
method were more reasonable. The risk of trimethoprim was identiﬁed
as insigniﬁcant risk using the RQ method (RQ = 0.07) and the opti-
mized method (PI = 0.001), but it should not be neglected completely
because of the 2% frequency of PNEC exceedance in surface waters of
China, especially in the water where trimethoprim posed a potential
risk to aquatic organisms.
The main disadvantage of the optimized method was that the PNECs
were derived from the most sensitive endpoints, which did not take into
account the range of species present in the environment. In relative
terms, the JPCs method incorporated variability in estimates of both
exposure and eﬀects, and then given out a reﬁned result. Take carba-
mazepine for instance, the frequency of PNEC exceedance was 67% and
the prioritization indexes was 43 that presented high risk, but the
probability of concentrations causing adverse eﬀects in 5% of species
was only 30%, which means it posed a low risk for waters when con-
sidering all the aquatic species. While the use of the JPC provides more
information, it also requires more information to provide complete
results and can thus be severely limited by a lack of information. In
addition, due to the log transformation performed, this approach also
Fig. 6. Joint probability curves for estimated measured environment con-
centrations (MECs) of 12 PPCPs in surface waters and species sensitivity dis-
tributions. The color of risk curves for hormones, antibiotics, other pharma-
ceuticals, PCPs are shown as red, blue, black, green, respectively. The font color
indicates the categorization of risk that identiﬁed these compounds: green: de
minimis risk, yellow: low risk, orange: intermediate risk, pink: high risk.
Fig. 7. Comparisons among point-estimates of exposure and eﬀects for 12
PPCPs. The horizontal lines represent 10th and 90th percentiles, and the boxes
represent 25th and 75th percentiles. Median concentrations are shown as solid
lines. Outliers (< 3 times higher of boxes) and extreme (> 3 times higher of
boxes) are shown as “○” and “*”, respectively.
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had the disadvantage that “0″ values are not allowed, which might limit
the utility of the method. For example, 17β-ethynyl estradiol presented
the greatest risk according to JPCs, but was less detected (68%) than
estrone (96%), 17β-estradiol (81%), and caﬀeine (100%) in surface
waters, so it may not be appropriate for identifying 17β-ethynyl es-
tradiol as the ﬁrst priority chemical.
4. Limitations
Rankings of chemicals carried out in this study were limited by
quantities and quality of available data on exposure and eﬀects. There
are many examples of measurements of hormones like 17β-ethynyl
estradiol, which are problematic due to their low concentrations in
aquatic environments (Hannah et al., 2009). Data used to estimate the
exposures of chemicals such as musks and iopromide were limited to
only 4 samples, and some chemicals were reported mostly for drinking
waters, while existing exposure information on heavily polluted surface
waters is sparse and limited. In similar cases, toxic potency data for
sensitive species are also limited for some chemicals, especially for
antibiotics, and potential drug resistance to multiple generations of
organisms have been ignored. There were also limitations imposed by
chiral chemicals that might have signiﬁcant diﬀerences in biode-
gradation and toxic potency among enantiomers (Wong, 2006). For
example, chronic responses of the fathead minnow (Pimephales pro-
melas) to enantiomers of propranolol followed the hypothesis that (S)-
propranolol is more toxic than (R)-propranolol (Stanley et al., 2006).
The enantioselective biodegradation and ecotoxicity of chiral PPCPs
tend to complicate their potential risk (Yin et al., 2016). Therefore, the
risks of such chemicals might have been underestimated or over-
estimated, and this is likely to change drastically as new information
becomes available.
Furthermore, the toxicity arising from complex mixtures of PPCPs at
low concentrations could lead to additive or synergistic interactions, as
demonstrated for similar acting compounds such as antibiotics or es-
trogens (Ferrari et al., 2004). This means that even though individual
PPCPs are present in low concentrations that do not elicit signiﬁcant
toxic eﬀects, PPCP mixtures can still exert considerable ecotoxicity.
PPCPs found in the aquatic environment usually occur as mixtures,
further research on the toxicity of the target compounds should include
not only the individual PPCPs but also mixtures of these compounds
(Altenburger et al., 2019; Brack et al., 2019).
In addition, this study was based solely on the measured con-
centrations and adverse eﬀects, but did not take into account the en-
vironmental behavior and bioaccumulation. According to Palma et al.
(2014), compounds with logKow higher than 3.0 show hydrophobic
behavior and have a high potential for bioaccumulation. For example,
the bioconcentration factors measured for ibuprofen and naproxen in
rainbow trout (Oncorhynchus mykiss) bile were 14,000–49,000
(Brozinski et al., 2013) and 500–2300 (Brozinski et al., 2011) respec-
tively, also Coogan et al. (2007) revealed the accumulation of triclosan
and triclocarban in ﬁlamentous algae species with the bioaccumulation
factor ranged from 900–2100 and 1600–2700 respectively, suggesting a
high bioconcentration in aquatic organisms (EU, 2007). In this study,
around 46% (23 out of 50) of PPCPs have high potentials for bioac-
cumulation (Table 1) and should be considered as priority at the same
risk level. A more thorough re-analysis of their position following
careful bioaccumulation considerations is necessary. Conclusions
The 50 selected PPCPs were frequently detected in surface waters of
China, with concentrations ranging from ng L−1 to the low-g L−1,
which were lower or comparable to those reported worldwide in most
cases. The risk quotients of the 50 PPCPs based on median concentra-
tions ranged from 2046 for nonylphenol to 0 for phantolide. When
considering all the concentrations analyzed in environment, 33 PPCPs
posed risks to the most sensitive aquatic organisms, among which 4
chemicals (caﬀeine, nonylphenol, tonalide, and galaxolide) posed an
ecological risk to 100% surface waters, and 15 chemicals (nonylphenol,
sulfamethoxazole, di (2-ethylhexyl) phthalate, 17β-ethynyl estradiol,
caﬀeine, tetracycline, 17β-estradiol, estrone, dibutyl phthalate, ibu-
profen, carbamazepine, tonalide, galaxolide, triclosan, and bisphenol
A) were identiﬁed as high or moderate risk according to prioritization
indexes. When considering all the aquatic ecosystems, 17β-ethynyl es-
tradiol, caﬀeine, estrone, and sulfamethoxazole posed high risks to
freshwater species.
The results of this study suggest that researchers should attempt to
rank PPCPs using multiple approaches for regulatory goals. In this way,
the RQ method may be more useful to prioritize substances at a speciﬁc
region than on a large scale, while the semi-probabilistic risk approach
can be used as initial identiﬁcation for chemicals that posed an aquatic
ecological risk at the national scale. The approach of prioritization in-
dexes incorporated various elements that determine target organism
exposure to a chemical would reduce uncertainty and could be con-
sidered by risk managers who need to make a decision requiring an
incremental quantiﬁcation of risks. The JPCs method that accounts for
variability in exposure and toxicity proﬁles is appropriate to estimate
environmental risk for the whole aquatic ecosystem posed by con-
taminants.
CRediT authorship contribution statement
Na Liu: Conceptualization, Investigation, Methodology, Software,
Visualization, Writing - original draft. Xiaowei Jin: Conceptualization,
Methodology, Supervision, Writing - review & editing. Chenglian
Feng:Writing - review & editing. Zijian Wang: Methodology, Writing -
review & editing. Fengchang Wu: Supervision, Writing - review &
editing. Andrew C. Johnson:Methodology, Writing - review & editing.
Hongxia Xiao: Writing - review & editing. Henner Hollert: Writing -
Table 3
Information obtained for each level of risk assessment.
Relative
ranking
Risk quotient Frequency of PNEC exceedance
(%)
Prioritization index Maximum risk product (%)
1 sulfamethoxazole (5964) nonylphenol (1 0 0) sulfamethoxazole (5666) 17β-ethynyl estradiol (17.38)
2 nonylphenol (4650) caﬀeine (1 0 0) nonylphenol (4651) caﬀeine (13.77)
3 17β-ethynyl estradiol (9 8 0) estrone (95) di (2-ethylhexyl) phthalate (7 6 2) sulfamethoxazole (13.76)
4 di (2-ethylhexyl) phthalate (8 1 7) sulfamethoxazole (94) 17β-ethynyl estradiol (6 8 6) estrone (12.39)
5 caﬀeine (6 1 6) di (2-ethylhexyl) phthalate (93) caﬀeine (6 1 6) nonylphenol (9.21)
6 tetracycline (3 3 6) bisphenol A (93) tetracycline (2 2 4) 17β-estradiol (8.12)
7 dibutyl phthalate (2 0 3) ibuprofen (89) 17β-estradiol (1 3 2) di (2-ethylhexyl) phthalate (8.06)
8 di-n-octyl phthalate(1 9 0) tetracycline (70) estrone (1 2 3) tetracycline (7.91)
9 17β-estradiol (1 6 3) 17β-estradiol (69) dibutyl phthalate (1 1 9) dibutyl phthalate (5)
10 estrone (1 2 7) 17β-ethynyl estradiol (68) ibuprofen (84) ibuprofen (3.29)
11 ibuprofen (94) carbamazepine (67) carbamazepine (43) bisphenol A (3)
12 carbamazepine (65) dibutyl phthalate (59) di-n-octyl phthalate (19) carbamazepine (1.54)
13 bisphenol A (15) di-n-octyl phthalate (10) bisphenol A (14) di-n-octyl phthalate ( − − −)
N. Liu, et al. Environment International 136 (2020) 105454
9
review & editing. John P. Giesy: Methodology, Software, Writing -
review & editing.
Declaration of Competing Interest
The authors declare that they have no known competing ﬁnancial
interests or personal relationships that could have appeared to inﬂu-
ence the work reported in this paper.
Acknowledgments
This research was ﬁnancially supported by the National Natural
Science Foundation of China (41807400, 41977364, 41521003,
41630645), Beijing outstanding talent training program.
Appendix A. Supplementary material
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.envint.2019.105454.
References
Altenburger, R., Brack, W., Burgess, R.M., et al., 2019. Future water quality monitoring:
improving the balance between exposure and toxicity assessments of real-world
pollutant mixtures. Environ. Sci. Eur. 31, 12.
Aslund, M.W., Breton, R.L., Padilla, L., Reiss, R., Winchell, M., Wooding, K., Moore,
D.R.J., 2016. Ecological risk assessment for Paciﬁc salmon exposed to dimethoate in
California. Environ Toxicol Chem. 36 (2), 532–543.
Balakrishna, K., Rath, A., Praveenkumarreddy, Y., Guruge, K.S., Subedi, B., 2017. A re-
view of the occurrence of pharmaceuticals and personal care products in Indian water
bodies. Ecotoxicol. Environ. Saf. 137, 113–120.
Barbara, K.H., Dinsdale, R.M., Guwy, A.J., 2008. The occurrence of pharmaceuticals,
personal care products, endocrine disruptors and illicit drugs in surface water in
South Wales. UK. Water Res. 42, 3498–3518.
Brack, W., Aissa, S.A., Backhaus, T., Dulio, V., et al., 2019. Eﬀect-based methods are key.
The European collaborative project solutions recommends integrating eﬀect-based
methods for diagnosis and monitoring of water quality. Environ. Sci. Eur. 31, 10–15.
Brozinski, J.M., Lahti, M., Oikari, A., Kronberg, L., 2011. Detection of naproxen and its
metabolites in ﬁsh bile following intraperitoneal and aqueous exposure. Environ. Sci.
Pollut. Res. Int. 18, 811–818.
Brozinski, J.M., Lahti, M., Oikari, A., Kronberg, L., 2013. Identiﬁcation and dose de-
pendency of ibuprofen biliary metabolites in rainbow trout. Chemosphere 93,
1789–1795.
Bu, Q., Wang, B., Huang, J., Deng, S., Yu, G., 2013. Pharmaceuticals and personal care
products in the aquatic environment in China: a review. J. Hazard. Mater. 262,
189–211.
Burns, E.E., Carter, L.J., Snape, J., et al., 2018. Application of prioritization approaches to
optimize environmental monitoring and testing of pharmaceuticals. J. Toxicol.
Environ. Health Part B 21 (3), 115–141.
Carlsson, C., Johansson, A.K., Alvan, G., Bergman, K., Kühler, T., 2006. Are pharma-
ceuticals potent environmental pollutants? Part I: environmental risk assessments of
selected active pharmaceutical ingredients. Sci. Total Environ. 364, 67–87.
Carmona, E., Andreu, V., Picó, Y., 2014. Occurrence of acidic pharmaceuticals and per-
sonal care products in Turia River Basin: from waste to drinking water. Sci. Total
Environ. 484, 53–63.
Chen, J.Q., Guo, R.X., 2012. Access the toxic eﬀect of the antibiotic cefradine and its UV
light degradation products on two freshwater algae. J. Hazard. Mater. 209–210,
520–523.
China Industry Research Net (CIRN), 2012. Personal care product market development
analysis. 23-24 (in Chinese).
Clemow, Y.H., Manning, G.E., Breton, R.L., Winchell, M.F., Padilla, L., Rodney, S.I., 2018.
A reﬁned ecological risk assessment for california red-legged frog, Delta Smelt, and
California tiger salamander exposed to Malathion. Integr. Environ. Assess. Manage.
14, 224–239.
Coogan, M.A., Edziyie, R.E., La Point, T.W., Venables, B.J., 2007. Algal bioaccumulation
of triclocarban, triclosan, and methyl-triclosan in a North Texas wastewater treat-
ment plant receiving stream. Chemosphere 67, 1911–1918.
Desbiolles, F., Malleret, L., Tiliacos, C., et al., 2018. Occurrence and ecotoxicological
assessment of pharmaceuticals: Is there a risk for the Mediterranean aquatic en-
vironment? Sci. Total Environ. 639, 1334–1348.
Donnachie, R.L., Johnson, A.C., Sumpter, J.P., 2016. A rational approach to selecting and
ranking some pharmaceuticals of concern for the aquatic environment and their re-
lative importance compared with other chemicals. Environ. Toxicol. Chem. 35,
1021–1027.
Durda, J.L., Preziosi, D.V., 2000. Data quality evaluation of toxicological studies used to
derive ecotoxicological benchmarks. Hum. Ecol. Risk Assess. 6 (5), 747–765.
Ebele, A.J., Abdallah, A.E.M., Harrad, S., 2017. Pharmaceuticals and personal care pro-
ducts (ppcps) in the freshwater aquatic environment. Emerging Contaminants. 3,
1–16.
European Commission (EC), 2003. Technical guidance document on risk assessment,
Joint Research Centre, Institute for Health and Comsumer Protection, European
Chemicals Bureau, Ispra, Italy.
European Union (EU), 2007. Registration, evaluation, authorization and restriction of
chemicals. European Parliament and Council, Brussels, Belgium.
Commission, European, 2015. Decision 495/2015/EU of 20 March 2015 establishing a
watch list of substances for union-wide monitoring in the ﬁeld of water policy pur-
suant to Directive C2008/105/EC of the European Parliament and of the Council. Oﬀ.
J. Eur. Union. 78, 40–42.
Fang, W.D., Peng, Y., Muir, D., Lin, J., Zhang, X.W., 2019. A critical review of synthetic
chemicals in surface waters of the US, the EU and China. Environ. Int. 131, 1–11.
Ferrari, B., Mons, R., Vollat, B., Nicklas, P., Giudice, R.L., Pollio, A., Garric, J., 2004.
Environmental risk assessment of six human pharmaceuticals: Are the current en-
vironmental risk assessment procedures suﬃcient for the protection of the aquatic
environment? Environ. Toxicol. Chem. 23 (5), 1344–1354.
Godoy, A.A., Kummrow, F., Pamplin, P.A.Z., 2015. Occurrence, ecotoxicological eﬀects
and risk assessment of antihypertensive pharmaceutical residues in the aquatic en-
vironment - A review. Chemosphere 138, 281–291.
Hannah, R., D'Aco, V.J., Anderson, P.D., Buzby, M.E., Caldwell, D.J., Cunningham, V.L.,
2009. Exposure assessment of 17 alpha-ethinylestradiol in surface waters of the
United States and Europe. Environ. Toxicol. Chem. 28, 2725–2732.
Hobbs, D.A., Warne, M.S.J., Markich, S.J., 2005. Evaluation of criteria used to assess the
quality of aquatic toxicity data. Integr. Environ. Assess. Manage. 1 (3), 174–180.
Jin, X.W., Wang, Y.Y., Jin, W., Rao, K.F., Giesy, J.P., Hollert, H., 2014. Ecological risk of
nonylphenol in China surface waters based on reproductive ﬁtness. Environ. Sci.
Technol. 48, 1256–1262.
Johnson, A.C., Jürgens, M.D., Su, C., Zhang, M., Zhang, Y., Shi, Y., 2018. Which com-
monly monitored high risk chemical in the Bohai Region, Yangtze and Pearl Rivers of
China poses the greatest threat to aquatic wildlife? Environ. Toxicol. Chem. 37 (4),
1115–1121.
Klimisch, H.J., Tillmann, U., 1997. A systematic approach for evaluating the quality of
experimental toxicological and ecotoxicological data. Regulatory Toxicol. Pharmacol.
Rtp. 25, 1–5.
Kumar, A., Xagoraraki, I., 2010. Human health risk assessment of pharmaceuticals in
water: an uncertainty analysis for meprobamate, carbamazepine, and phenytoin.
Regul. Toxicol. Pharm. 57 (2–3), 146–156.
Kuzmanović, M., Ginebreda, A., Petrovič, M., Barceló, D., 2015. Risk assessment based
prioritization of 200 organic micropollutants in 4 Iberian rivers. Sci. Total Environ.
503–504, 289–299.
Kolpin, D.W., Furlong, E.T., Meyer, M.T., Thurman, E.M., Zaugg, S.D., Barber, L.B., 2002.
Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S.
streams, 1999–2000: A national reconnaissance. Environ. Sci. Technol. 36,
1202–1211.
Larsson, D.G.J., Pedro, C.D., Paxeus, N., 2007. Eﬄuent from drug manufactures contains
extremely high levels of pharmaceuticals. J. Hazard. Mater. 148, 751–755.
Liu, J.L., Wong, M.H., 2013. Pharmaceuticals and personal care products (PPCPs): A re-
view on environmental contamination in China. Environ. Int. 59 (3), 208–224.
Liu, N., 2016. Study for reproductive toxicity eﬀect and ecological risk assessment of
typical PPCPs. China University of Geosciences (Beijing), Beijing, China (in Chinese).
Liu, N., Wang, Y.Y., Yang, Q., Lv, Y.B., Jin, X.W., Giesy, J.P., Johnson, A.J., 2016a. a.
Probabilistic assessment of risks of diethylhexyl phthalate (DEHP) in surface waters
of China on reproduction of ﬁsh. Environ. Pollut. 213, 482–488.
Liu, N., Jin, X.W., Wang, Y.Y., Wang, Z.J., 2016b. b. Review of criteria for screening and
evaluating ecotoxicity data. Asian J. Ecotoxicol. 11, 1–10 (in Chinese).
Loos, R., Gawlik, B.M., Locoro, G., Rimaviciute, E., Contini, S., Bidoglio, G., 2009. EU-
wide survey of polar organic persistent pollutants in European river waters. Environ.
Pollut. 157 (2), 561–568.
Ågerstrand, M., Rudén, C., 2010. Evaluation of the accuracy and consistency of the
Swedish environmental classiﬁcation and information system for pharmaceuticals.
Sci. Total Environ. 408, 2327–2339.
Mebane, C.A., 2010. Relevance of risk predictions derived from a chronic species sensi-
tivity distribution with cadmium to aquatic populations and ecosystems. Risk Anal.
30 (2), 203–223.
Meng, L., Yang, B., Xue, N.D., Zhang, S.L., Li, F.S., Liu, H.B., 2015. A review on en-
vironmental behaviors and ecotoxicology of ﬂuoroquinolone antibiotics. Asian J.
Ecotoxicol. 10, 76–88 (in Chinese).
Moermond, C.T.A., Kase, Y.R., Korkaric, Z.M., Muris, Å., 2016. CRED: criteria for re-
porting and evaluating ecotoxicity data. Environ. Toxicol. Chem. 35 (5), 1297–1309.
Moore, D.R.J., Teed, R.S., Rodney, S.I., Thompson, R.P., Fischer, D.L., 2010. Reﬁned
aquatic risk assessment for aldicarb in the United States. Integr Environ Assess
Manag. 6 (1), 102–118.
Moore, D.R.J., Teed, R.S., Greer, C.D., Solomon, K.R., Giesy, J.P., 2014. Reﬁned avian risk
assessment for chlorpyrifos in the United States. Rev Environ Contam Toxicol. 231,
163–217.
Nakada, N., Komori, K., Suzuki, Y., Konishi, C., Houwa, I., Tanaka, H., 2007. Occurrence
of 70 pharmaceutical and personal care products in tone river basin in Japan. Water
Sci. Technol. 56 (12), 133–140.
NORMAN Association, 2013. NORMAN Prioritisation framework for emerging sub-
stances. ISBN : 978-2-9545254-0-2.
Ohe, P.C.V.D., Dulio, V., Slobodnik, J., Deckere, E.D., Kühne, R., Ebert, R.U., Ginebreda,
A., Cooman, W.D., Schüürmann, G., Brack, W., 2011. A new risk assessment approach
for the prioritization of 500 classical and emerging organic microcontaminants as
potential river basin speciﬁc pollutants under the European Water Framework
Directive. Sci. Total Environ. 409 (11), 2064–2077.
Palma, P., Köck-Schulmeyer, M., Alvarenga, P., Ledo, L., Barbosa, I.R., López de Alda, M.,
Barceló, D., 2014. Risk assessment of pesticides detected in surface water of the
N. Liu, et al. Environment International 136 (2020) 105454
10
Alqueva reservoir (Guadiana basin, southern of Portugal). Sci. Total Environ. 488,
208–219.
Rehman, M.S., Rashid, N., Ashfaq, M., Saif, A., Ahmad, N., Han, J.I., 2015. Global risk of
pharmaceutical contamination from highly populated developing countries.
Chemosphere 138, 1045–1055.
Santos, L.H., Araújo, A.N., Fachini, A., Pena, A., Deleruematos, C., Montenegro, M.C.,
2010. Ecotoxicological aspects related to the presence of pharmaceuticals in the
aquatic environment. J. Hazard. Mater. 175 (1), 45–95.
Scheurer, M., Sacher, F., Brauch, H.J., 2009. Occurrence of the antidiabetic drug met-
formin in sewage and surface waters in Germany. J. Environ. Monit. 11, 1608–1613.
Sharma, B.M., Bečanová, J., Scheringer, M., Sharma, A., Bharat, G.K., Whitehead, P.G.,
Klánová, J., Nizzetto, L., 2019. Health and ecological risk assessment of emerging
contaminants (pharmaceuticals, personal care products, and artiﬁcial sweeteners) in
surface and groundwater (drinking water) in the Ganges River Basin. India. Sci. Total
Environ. 646, 1459–1467.
Sim, W.J., Lee, J.W., Lee, E.S., Shin, S.K., Hwang, S.R., Oh, J.E., 2011. Occurrence and
distribution of pharmaceuticals in wastewater from households, livestock farms,
hospitals and pharmaceutical manufactures. Chemosphere 82, 179–186.
Smital, T., Terzić, S., Lončar, J., Senta, I., Žaja, R., Popović, M., Mikac, I., Tollefsen, K.-E.,
Thomas, K.V., Ahel, M., 2013. Prioritisation of organic contaminants in a river basin
using chemical analyses and bioassays. Environ. Sci. Pollut. Res. 20, 1384–1395.
Solomon, K., Giesy, J.P., 2000. Probabilistic risk assessment of agrochemicals in the en-
vironment. Crop Prot. 19, 649–655.
Stanley, J.K., Ramirez, A.J., Mottaleb, M., Chambliss, C.K., Brooks, B.W., 2006.
Enantiospeciﬁc toxicity of the beta-blocker propranolol to Daphnia magna and
Pimephales promelas. Environ. Toxicol. Chem. 25, 1780–1786.
Sui, Q., Wang, B., Zhao, W.T., Huang, J., Yu, G., Deng, S.B., Qiu, Z.F., Lu, S.G., 2012.
Identiﬁcation of priority pharmaceuticals in the water environment of China.
Chemosphere 89 (3), 280–286.
Sun, J., Luo, Q., Wang, D., Wang, Z., 2015. Occurrences of pharmaceuticals in drinking
water sources of major river watersheds. China. Ecotoxicol. Environ. Safety 117,
132–140.
Tarazona, J.V., Escher, B.I., Giltrow, E., Sumpter, J., Knacker, T., 2010. Targeting the
environmental risk assessment of pharmaceuticals: facts and fantasies. Integr.
Environ. Assess. Manage. 6, 603–613.
Tewari, S., Jindal, R., Kho, Y.L., Eo, S., Choi, K., 2013. Major pharmaceutical residues in
wastewater treatment plants and receiving waters in Bangkok, Thailand, and asso-
ciated ecological risks. Chemosphere 91 (5), 697–704.
Thomaidi, V.S., Stasinakis, A.S., Borova, V.L., Thomaidis, N.S., 2015. Is there a risk for the
aquatic environment due to the existence of emerging organic contaminants in
treated domestic wastewater? Greece as a case-study. J. Hazard. Mater. 283,
740–747.
Tousova, Z., Oswald, P., Slobodnik, J., Blaha, L., Muz, Me, Hu, M., 2017. European de-
monstration program on the eﬀect-based and chemical identiﬁcation and monitoring
of organic pollutants in European surface waters. Sci. Total Environ. 601–602,
1849–1868.
US EPA, 1992. Framework for ecotoxicological risk assessment, United States
Environmental Protection Agency, Washington, DC.
US EPA, 1996. Guidelines for reproductive toxicity risk assessment, United States
Environmental Protection Agency, Washington, DC.
US EPA, 1998. Guidelines for ecological risk assessment., United States Environmental
Protection Agency, Washington, DC.
US EPA, 2011. Evaluation guidelines for ecological toxicity data in the open literature.
Washington, DC: US EPA.
Vazquez-Roig, P., Andreu, V., Blasco, C., Picó, Y., 2012. Risk assessment on the presence
of pharmaceuticals in sediments, soils and waters of the Pego-Oliva Marshlands
(Valencia, eastern Spain). Sci. Total Environ. 440 (3), 24–32.
Vieno, N., Tuhkanen, T., Kronberg, L., 2007. Elimination of pharmaceuticals in sewage
treatment plants in Finland. Water Res. 41 (5), 1001–1012.
Wang, Z., Du, Y., Yang, C., Liu, X., Zhang, J., Li, E., 2017. Occurrence and ecological
hazard assessment of selected antibiotics in the surface waters in and around Lake
Honghu. China. Sci. Total Environ. 609, 1423–1432.
Watkinson, A.J., Murby, E.J., Kolpin, D.W., Costanzo, S.D., 2009. The occurrence of an-
tibiotics in an urban watershed: from wastewater to drinking water. Sci. Total
Environ. 407, 2711–2723.
Wong, C.S., 2006. Environmental fate processes and biochemical transformations of
chiral emerging organic pollutants. Anal. Bioanal. Chem. 386, 544–558.
Yao, H., Li, Q., Zheng, H., Wu, Y., Zhang, W., 2011. Determination and analysis of the ﬁve
phthalates in environmental water samples in Anshan city. Sciencepaper Online. 6,
692–695.
Yao, L.L., Wang, Y.X., Tong, L., Deng, Y.M., Li, Y.G., Gan, Y.Q., Guo, W., Dong, C.G.,
Duan, Y.H., Zhao, K., 2017. Occurrence and risk assessment of antibiotics in surface
water and groundwater from diﬀerent depths of aquifers: A case study at Jianghan
Plain, central China. Ecotoxicol. Environ. Saf. 135, 236–242.
Yin, L., Wang, B., Ma, R., Yuan, H., Yu, G., 2016. Enantioselective environmental beha-
vior and eﬀect of chiral PPCPs. Prog. Chem. 28 (5), 744–753 (in Chinese).
Yu, Z.Y., Jiang, L., Yin, D.Q., 2011. Behavior toxicity to Caenorhabditis elegans transferred
to the progeny after exposure to sulfamethoxazole at environmentally relevant con-
centrations. J. Environ. Sci. 23 (2), 294–300.
Yu, Z.R., 2011. Distribution and puriﬁcation of pharmaceutical and personal care pro-
ducts (PPCPs) in drinking water. Tsinghua University, Beijing, China (in Chinese).
Zhang, A., Li, Y., Chen, L., 2014. Distribution and seasonal variation of estrogenic en-
docrine disrupting compounds, N-nitrosodimethylamine, and N- ni-
trosodimethylamine formation potential in the Huangpu River. China. J. Environ. Sci.
26 (5), 1023–1033.
Zhang, M., Shi, Y., Lu, Y., Johnson, A.C., Sarvajayakesavalu, S., Liu, Z., Su, C., Zhang, Y.,
Jurgens, M.D., 2017a. a. The relative risk and its distribution of endocrine disrupting
chemicals pharmaceuticals and personal care products risk to freshwater organisms
in Bohai Rim. China. Sci. Total Environ. 590, 633–642.
Zhang, L., Wei, C., Zhang, H., Song, M., 2017b. b. Criteria for assessing the ecological risk
of nonylphenol for aquatic life in Chinese surface fresh water. Chemosphere 184,
569–574.
Zhang, Q.Q., Ying, G.G., Pan, C.G., Liu, Y.S., Zhao, J.L., 2015. A comprehensive eva-
luation of antibiotics emission and fate in the river basins of China: source analysis,
multimedia modeling, and linkage to bacterial resistance. Environ. Sci. Technol. 49,
6772–6782.
Zhao, J., Liu, Y., Mei, S., Tian, X., 2012. Determination of iopromide in water environ-
ment by SPE-HPLC. Environ. Sci. Manage. 37 (1), 133–136 (in Chinese).
Zhou, H., Wu, C., Huang, X., Gao, M., Wen, X., Tsuno, H., Tanaka, H., 2010. Occurrence of
selected pharmaceuticals and caﬀeine in sewage treatment plants and receiving rivers
in Beijing. China. Water Environ. Res. 82 (11), 2239–2248.
Zhou, X.F., Dai, C.M., Zhang, Y.L., Surampalli, R.Y., Zhang, T.C., 2011. A preliminary
study on the occurrence and behavior of carbamazepine (CBZ) in aquatic environ-
ment of yangtze river delta. China. Environ. Monitor. Assess. 173, 45–53.
Zhou, S.B., Paolo, C.D., Wu, X.D., Shao, Y., Seiler, T.B., Hollert, H., 2019. Optimization of
screening-level risk assessment and priority selection of emerging pollutants - The
case of pharmaceuticals in European surface waters. Environ. Int. 128, 1–10.
N. Liu, et al. Environment International 136 (2020) 105454
11
